LakeShore Biopharma Announces Financial Results for Fiscal Year 2024
Provided By PR Newswire
Last update: Aug 15, 2024
Gross margin increased to 79.5%; product pipeline continues to advance
Company anticipates double-digit year-over-year revenue growth and bottom line breakeven for Fiscal Year 2025
Read more at prnewswire.com1.11
+0.03 (+2.78%)
Find more stocks in the Stock Screener
LSB Latest News and Analysis
6 days ago - ChartmillThese stocks are moving in today's pre-market sessionLet's have a look at what is happening on the US markets before the opening bell on Wednesday. Below you can find the top gainers and losers in today's pre-market session.
